Track the Quoin Pharmaceuticals, Ltd. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €12.3m. The latest transaction was filed on 1 September 2026 (Acquisition). Among the most active insiders: Myers Michael. The full history is free.
15
Insider Decl.
n/a
Thresholds
€929,511
12 ops.
Buy Volume
€200
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Quoin Pharmaceuticals, Ltd. Strong Buy (bullish), based on 5 analysts. Average price target: US$21.40.
54Σ signal
Buys €929,511€200 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
297 shares@ US$0.732100.0% of flowOrdinary SharesSEC:0001104659-24-070017:0
15 of 15 declarations
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. is a pharmaceutical company focused on developing treatments for rare diseases and skin disorders. It is listed on NASDAQ under the ticker QNRX.